<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Gastroenterology Headlines</title>
		<link>http://www.medscape.com/gastroenterology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Gastroenterology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Gastroenterology Headlines</title>
			<link>http://www.medscape.com/gastroenterology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2009, Medscape</copyright>
		<pubDate>Sat, 7 Nov 2009 22:34:43 EST</pubDate>
		<managingEditor>gastroeditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Infant Rotavirus Vaccine Reduced Diarrhea-Related Hospitalizations, ED Visits, and Outpatient Visits</title>
			<link>http://www.medscape.com/viewarticle/712002?src=rss</link>
			<description>The pentavalent rotavirus vaccine is safe and effective and greatly reduces resource use and expenditures related to diarrheal illness in infants younger than 1 year of age.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Infectious Diseases</category>
					<pubDate>Sat, 7 Nov 2009 14:56:32 EST</pubDate>
		</item>
		<item>
			<title>Natalizumab Reduces Hospitalization Rates for Crohn&apos;s DiseaseNatalizumab Reduces Hospitalization Rates for Crohn&apos;s Disease</title>
			<link>http://www.medscape.com/viewarticle/712001?src=rss</link>
			<description>Anti-tumor necrosis factor-resistant Crohn&apos;s disease responds to treatment with natalizumab.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Sat, 7 Nov 2009 14:50:20 EST</pubDate>
		</item>
		<item>
			<title>Epidemic of Sexually Transmitted HCV in HIV-Infected Men Reported in New York</title>
			<link>http://www.medscape.com/viewarticle/712000?src=rss</link>
			<description>Sexual transmission  has been a rare route of HCV transmission, but epidemic rates are being reported in New York City in HIV-infected men, characterized by rapid progression to hepatitis fibrosis.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Sat, 7 Nov 2009 14:43:31 EST</pubDate>
		</item>
		<item>
			<title>Changes in Growth Seen in Children on Peginterferon for Chronic HCV Infection</title>
			<link>http://www.medscape.com/viewarticle/711999?src=rss</link>
			<description>Even 1 year off-treatment, linear growth has not recovered in children younger than 16 years of age given peginterferon alfa for chronic hepatitis C virus infection.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Sat, 7 Nov 2009 14:36:13 EST</pubDate>
		</item>
		<item>
			<title>New Combination Drug Improves Gastroprotection, Adherence Compared With EC Naproxen Alone</title>
			<link>http://www.medscape.com/viewarticle/711964?src=rss</link>
			<description>Enteric-coated naproxen 500 mg + immediate-release esomeprazole 20 mg improves gastrointestinal symptoms, and the fixed-dose combination  promotes adherence to long-term NSAID therapy.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Fri, 6 Nov 2009 12:53:02 EST</pubDate>
		</item>
		<item>
			<title>Analysis of the Efficacy of Treatment With Peginterferon Alpha-2a and Ribavirin in Patients Coinfected With Hepatitis B Virus And Hepatitis C Virus</title>
			<link>http://www.medscape.com/viewarticle/710265?src=rss</link>
			<description>Investigators examined the virologic features of patients coinfected with HBV and HCV and the efficacy of combination therapy with peginterferon alpha-2a and ribavirin in these patients.  &lt;br /&gt; &lt;i&gt;Liver International&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Fri, 6 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>Vitamin D Has Benefits in Chronic HCV Infection</title>
			<link>http://www.medscape.com/viewarticle/711902?src=rss</link>
			<description>Vitamin D supplementation improved standard antiviral treatment efficacy in a small study.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Thu, 5 Nov 2009 16:25:18 EST</pubDate>
		</item>
		<item>
			<title>Low Factor V Levels Signal Poor Prognosis With Hepatitis B-Induced Acute Liver Failure</title>
			<link>http://www.medscape.com/viewarticle/711860?src=rss</link>
			<description>Factor V level on day 3 of hospitalization was strongly associated with survival in HBV-associated acute liver failure, with levels of 0% to 10% among those who died and 7% to 25% for survivors.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pathology &amp; Lab Medicine</category>
					<pubDate>Thu, 5 Nov 2009 10:33:15 EST</pubDate>
		</item>
		<item>
			<title>Pegylated Interferon Alpha-2b (Peg-IFN alpha-2b) Affects Early Virologic Response Dose-Dependently in Patients With Chronic Hepatitis C Genotype 1 During Treatment With Peg-IFN Alpha-2b Plus Ribavirin</title>
			<link>http://www.medscape.com/viewarticle/709161?src=rss</link>
			<description>This study sought to evaluate how reducing drug doses affects complete early virologic response (c-EVR), defined as hepatitis C virus (HCV) RNA negativity at week 12.  &lt;br /&gt; &lt;i&gt;Journal of Viral Hepatitis&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Thu, 5 Nov 2009 08:32:46 EST</pubDate>
		</item>
		<item>
			<title>Serum BLyS/BAFF Predicts the Outcome of Acute Hepatitis C Virus Infection</title>
			<link>http://www.medscape.com/viewarticle/709176?src=rss</link>
			<description>This study examined serum levels of BLyS/BAFF in patients with acute hepatitis C (AHC) and sought to correlate them with disease outcome.  &lt;br /&gt; &lt;i&gt;Journal of Viral Hepatitis&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Fri, 6 Nov 2009 13:04:30 EST</pubDate>
		</item>
		<item>
			<title>HBV Reduces Recurrence-Free Survival After Surgery for Hepatocellular Carcinoma</title>
			<link>http://www.medscape.com/viewarticle/711832?src=rss</link>
			<description>In cirrhotic patients, hepatitis B virus (HBV) infection is associated with a poorer long-term prognosis after hepatectomy for hepatocellular carcinoma, according to Italian researchers.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>General Surgery</category>
					<pubDate>Thu, 5 Nov 2009 11:52:59 EST</pubDate>
		</item>
		<item>
			<title>Physicians Are Talking About: A Death Foretold</title>
			<link>http://www.medscape.com/viewarticle/711634?src=rss</link>
			<description>Would you operate on a patient who experienced a premonition of death?  Is this a contraindication surgery? Medscape Physician Connect members discuss whether to ignore or heed premonitions.  &lt;br /&gt; &lt;i&gt;Medscape Family Medicine&lt;/i&gt;</description>
			<category>Family Medicine/Primary Care</category>
					<pubDate>Wed, 4 Nov 2009 11:14:29 EST</pubDate>
		</item>
		<item>
			<title>Many Common Loci Associated With Early- and Adult-Onset Inflammatory Bowel Disease</title>
			<link>http://www.medscape.com/viewarticle/711777?src=rss</link>
			<description>Colonic expression of interleukin-27 is lower in patients with Crohn&apos;s disease than in normal control subjects.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pathology &amp; Lab Medicine</category>
					<pubDate>Wed, 4 Nov 2009 10:42:12 EST</pubDate>
		</item>
		<item>
			<title>Virulent Strain of C difficile on the Rise in Hospital and Community Settings</title>
			<link>http://www.medscape.com/viewarticle/711769?src=rss</link>
			<description>Physicians need to consider Clostridium difficile in patients with diarrhea, even those with no history of recent antibiotic use or hospitalization.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Wed, 4 Nov 2009 09:19:03 EST</pubDate>
		</item>
		<item>
			<title>Once-Daily Mesalamine as Effective as Twice-Daily Treatment for Maintenance of Remission in UC</title>
			<link>http://www.medscape.com/viewarticle/711692?src=rss</link>
			<description>Patients with ulcerative colitis are more compliant with once-daily delayed-release mesalamine without a loss of efficacy in maintaining remission over the standard twice-daily regimen.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Tue, 3 Nov 2009 10:14:38 EST</pubDate>
		</item>
		<item>
			<title>Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer</title>
			<link>http://www.medscape.com/viewarticle/711284?src=rss</link>
			<description>Prospectively collected resource utilization and health utility data for patients with CRC in the CO.17 study who received best supportive care +/- cetuximab were assessed for cost effectiveness.  &lt;br /&gt; &lt;i&gt;Journal of the National Cancer Institute&lt;/i&gt;</description>
			<category>Hematology-Oncology</category>
					<pubDate>Tue, 3 Nov 2009 12:00:00 EST</pubDate>
		</item>
		<item>
			<title>LAC and LOAD: 4-Drug Regimen Better at Eliminating H Pylori Than Standard 3-Drug Treatment</title>
			<link>http://www.medscape.com/viewarticle/711657?src=rss</link>
			<description>LOAD (levofloxacin, omeprazole, nitazoxanide, and doxycycline) is more effective at eradicating Helicobacter pylori than LAC (lansoprazole, amoxicillin, and clarithromycin).  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Mon, 2 Nov 2009 17:02:58 EST</pubDate>
		</item>
		<item>
			<title>Extended HCV Treatment After Liver Transplant Has Benefits</title>
			<link>http://www.medscape.com/viewarticle/711653?src=rss</link>
			<description>A new study challenges &quot;stop rules&quot; on antiviral treatment after transplantation when there is no response by 24 weeks.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Mon, 2 Nov 2009 16:15:54 EST</pubDate>
		</item>
		<item>
			<title>Children&apos;s Hospitals Often Do Not Follow Gastroenteritis Guidelines</title>
			<link>http://www.medscape.com/viewarticle/711652?src=rss</link>
			<description>Children&apos;s hospitals in the US commonly use resources not routinely recommended by published guidelines for the management of acute gastroenteritis, according to results of a study published online Monday in Pediatrics.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Pediatrics</category>
					<pubDate>Tue, 3 Nov 2009 14:42:36 EST</pubDate>
		</item>
		<item>
			<title>Drinking Coffee Daily Linked to Lower Risk for Progression of Chronic Hepatitis C</title>
			<link>http://www.medscape.com/viewarticle/711609?src=rss</link>
			<description>In a large prospective study, regular coffee drinking consumption was associated with lower rates of progression of advanced hepatitis C&#8211;related liver disease.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Gastroenterology</category>
					<pubDate>Mon, 2 Nov 2009 13:40:05 EST</pubDate>
		</item>

</channel>
</rss>